Osteoporosis
📧 Sign up to get email alerts when something new happens for Osteoporosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: Effect of Exercise and Phytoestrogen on Bone, Metabolic Syndrome Criteria and Complaints of the Early Menopause [Phase 3]
A Phase 3 trial evaluating exercise and phytoestrogen effects on bone health, metabolic syndrome criteria, and early menopause symptoms was …
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: Strength Training for Older Breast Cancer Survivors [NA]
This clinical trial update notes the strength training study for older breast cancer survivors has completed, with conditions including brea…
-
FDA approval · 2015-05-27FDA Approved: ZOLEDRONIC ACID — Supplemental Application (BPI Labs LLC)
FDA approved a supplemental application for zoledronic acid from BPI Labs LLC under an ANDA.
-
CLINICAL_TRIALS trial_result · 2015-05-25Clinical Trial Update: Effects of Proteins Fraction Derived From Milk on Osteoporosis Prevention [Phase 1]
Phase 1 trial evaluating a milk-derived protein fraction for osteoporosis prevention has completed, with no efficacy results provided in the…
-
FDA approval · 2015-05-21FDA Approved: PROLIA — Supplemental Application (Amgen, Inc)
The FDA approved Amgen's supplemental application for Prolia (denosumab).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Effects of Phytoestrogen-rich Diets on Bone Turnover in Postmenopausal Women [NA]
A completed clinical trial examined whether phytoestrogen-rich diets affect bone turnover in postmenopausal women with osteoporosis.
-
CLINICAL_TRIALS trial_result · 2015-05-15Clinical Trial Update: Effect of a Tablet-administered Educational Video on Patients´ Knowledge on Osteoporosis and Treatment [NA]
A completed trial evaluating whether a tablet-based educational video improves patients’ knowledge about osteoporosis and its treatment.
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Denosumab in Current Users of Bisphosphonates for Glucocorticoid-induced Osteoporosis [Phase 4]
This Phase 4 trial update reports completion of a study evaluating denosumab in patients with glucocorticoid-induced osteoporosis who are cu…
-
CLINICAL_TRIALS trial_result · 2015-05-08Clinical Trial Update: Nitrates and Bone Turnover; Nitrates and Bone Turnover Bisphosphonate Sub-Study [Phase 3]
Phase 3 trial update examining nitrates on bone turnover in osteoporosis, with a bisphosphonate sub-study; results were posted in May 2015.
-
CLINICAL_TRIALS trial_result · 2015-05-04Clinical Trial Update: ONO-5920/YM529 Confirmatory Study in Involutional Osteoporosis Patients [Phase 2, Phase 3]
The confirmatory study of ONO-5920/YM529 in involutional osteoporosis (Phase 2/Phase 3) has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: A Study of Arzoxifene to Treat Korean Women With Osteoporosis [Phase 2]
A Phase 2 study of arzoxifene for osteoporosis in Korean women has completed. The sponsor is Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: A Study to Assess the Disturbances in Calcitonin Gene in Patients With Gum Disease and Osteoporosis
A completed clinical trial evaluating disturbances in the Calcitonin gene in patients with generalized chronic periodontitis and osteoporosi…
-
CLINICAL_TRIALS trial_result · 2015-04-17Clinical Trial Update: Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan
A completed post-marketing surveillance study in Japan evaluating Julina for postmenopausal osteoporosis.
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Efficacy of Cinacalcet in the Control of Primary Hyperparathyroidism [Phase 4]
A Phase 4 trial evaluated the efficacy of cinacalcet in controlling primary hyperparathyroidism, and the study is reported as completed.
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Soluble Corn Fiber Effect on Bone Resorption in Post Menopausal Women [NA]
A completed Purdue University clinical trial investigated whether soluble corn fiber influences bone resorption in postmenopausal women with…
-
CLINICAL_TRIALS trial_result · 2015-04-14Clinical Trial Update: The Forteo Alendronate Comparator Trial [Phase 4]
This update reports that a Phase 4 trial comparing Forteo (teriparatide) to alendronate for osteoporosis has completed. The snippet does not…
-
FDA approval · 2015-04-09FDA Approved: ZOLEDRONIC ACID — Supplemental Application (Dr.Reddy's Laboratories Ltd)
FDA approved a supplemental application for zoledronic acid from Dr. Reddy's Laboratories Ltd (ANDA 091363), granting regulatory approval of…
-
FDA approval · 2015-04-08FDA Approved: ACTONEL — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Actonel (risendronate sodium) submitted by Allergan, Inc.
-
FDA approval · 2015-04-08FDA Approved: PROLIA — Supplemental Application (Amgen, Inc)
FDA approved a supplemental application for PROLIA (denosumab) submitted by Amgen, Inc.
-
FDA approval · 2015-04-08FDA Approved: FOSAMAX — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Fosamax (alendronate sodium) submitted by Organon LLC.
-
FDA approval · 2015-04-08FDA Approved: FOSAMAX PLUS D — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Fosamax Plus D (alendronate sodium and cholecalciferol) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2015-04-01Clinical Trial Update: Thiazolidinediones (TZD) Bone Loss and the Effects on Bone Marrow Differentiation and Osteoblast Formation
This completed clinical trial update investigates how thiazolidinediones affect bone loss, bone marrow differentiation, and osteoblast forma…
-
CLINICAL_TRIALS research · 2015-03-31Clinical Trial Update: Osteoporosis Associated Vertebral Fractures - Medical and Socio-economic Aspects in Austria
A completed clinical trial in Austria studied medical and socio-economic aspects of osteoporosis-associated vertebral fractures.
-
FDA approval · 2015-03-26FDA Approved: ACTONEL — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Actonel (risedronate sodium) submitted by Allergan, expanding its labeling for additional os…
-
FDA approval · 2015-03-26FDA Approved: ATELVIA — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Atelvia (risendronate sodium) filed by Allergan, expanding/ updating the product's labeling thro…